Advancement in the development of DNA vaccines against Trypanosoma brucei and future perspective
- 31 July 2024
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 140, 112847
Abstract
No abstract availableKeywords
Funding Information
- Shantou University Medical College (350 510859066)
This publication has 59 references indexed in Scilit:
- Biodegradable Microrobots for DNA Vaccine DeliveryAdvanced Healthcare Materials, 2023
- Immunoinformatic design of a putative multi-epitope vaccine candidate against Trypanosoma brucei gambienseComputational and Structural Biotechnology Journal, 2022
- mRNA vaccines in the prevention and treatment of diseasesMedcomm, 2022
- Trypanosoma brucei: Immunisation with plasmid DNA encoding invariant surface glycoprotein gene is able to induce partial protection in experimental African trypanosomiasisExperimental Parasitology, 2011
- Multifunctional core-shell polymeric nanoparticles for transdermal DNA delivery and epidermal Langerhans cells trackingBiomaterials, 2010
- Trans-sialidase from Trypanosoma brucei as a potential target for DNA vaccine development against African trypanosomiasisParasitology Research, 2009
- Lipid-based delivery of CpG oligonucleotides enhances immunotherapeutic efficacyAdvanced Drug Delivery Reviews, 2009
- Hydrodynamic Flow-Mediated Protein Sorting on the Cell Surface of TrypanosomesCell, 2007
- Comparative scale-up of three methods for producing ibuprofen-loaded nanoparticlesEuropean Journal of Pharmaceutical Sciences, 2005
- Cytokines in the pathogenesis of human African trypanosomiasis: antagonistic roles of TNF-α and IL-101999